U.S. Consumer Durables Stock News

If you are wondering whether Lithia Motors at around US$290.90 is a bargain or a value trap, a good starting point is understanding how its current share price compares to different measures of fair value. The stock has recently seen a 5.8% move over 7 days and a 16.0% change over 30 days, while the return year to date is a 12.5% decline and the 1 year return is a 1.1% decline, with a 37.5% gain over 3 years and a 20.9% decline over 5 years. Recent news coverage has focused on Lithia Motors...

Recent performance context for Kingsoft Cloud Holdings With no single headline event driving attention today, Kingsoft Cloud Holdings (KC) is drawing interest after a recent share price of US$15.00 and mixed return patterns across different time frames. Over the past month, the stock shows a 7.91% gain, while the past 3 months reflect a 13.55% return. Year to date, the move sits at 37.24%, compared with a 1.51% decline over the past year. See our latest analysis for Kingsoft Cloud...

Formula One Group and Pacsun announced an official Formula 1 Miami Grand Prix 2026 Collection, expanding F1 branded fashion into the U.S. retail market. The collection focuses on race inspired designs and is tied to the Miami Grand Prix weekend, targeting Gen Z and millennial shoppers. The move reflects Formula One Group's push to extend its brand into lifestyle and streetwear beyond the core motorsports audience. For investors tracking NasdaqGS:FWON.K, this Pacsun collaboration adds...

Constellation Brands (NYSE:STZ) has introduced Modelo Chelada Suprema, a new high-ABV ready-to-drink product under the Modelo label. The launch is nationwide and focuses on bold, fruit-forward flavors aimed at Gen Z and Millennial drinkers. This is the first high-ABV RTD offering tied to the top-selling Modelo brand in Constellation’s portfolio. For investors tracking NYSE:STZ, this launch sits at the intersection of two important themes: premium Mexican beer and the expanding RTD alcoholic...

Atmus Filtration Technologies (ATMU) has just put fresh numbers on the board for Q1 2026, coming off a recent quarter where Q4 2025 revenue was US$446.6 million and basic EPS was US$0.59, backed by trailing 12 month EPS of US$2.52 and net income of US$207.4 million. Over the past year, the company has seen revenue move from US$406.7 million in Q4 2024 to US$446.6 million in Q4 2025, while quarterly EPS shifted from US$0.48 to US$0.59, setting up this latest print against a backdrop of higher...

Estée Lauder Companies (EL) has put fresh numbers on the table for its latest quarter, with Q2 2026 revenue of US$4.2b and basic EPS of US$0.45, set against a trailing twelve month picture that still shows a basic EPS loss of US$0.49 on revenue of US$14.7b. Over recent quarters, the company has seen revenue move between US$3.4b and US$4.0b in fiscal 2025, before reaching US$3.5b in Q1 2026 and US$4.2b in Q2 2026. Basic EPS has ranged from losses of around US$1.64 per share to a recent profit...

If you are wondering whether Dave's share price still offers value or if the best of the move is already behind it, the next sections will break down what the current price might be implying. After closing at US$272.65, Dave has seen a 57.2% move over the past 30 days, with returns of 24.2% year to date and 160.4% over the last year, although the past week shows a modest 0.7% decline. The share price performance sits against a backdrop of ongoing interest in consumer finance platforms and...

A. O. Smith (NYSE:AOS) reported Q1 2026 results that missed expectations, citing weak demand in China and production issues at its Ashland City facility. The company lowered its full-year 2026 guidance for both sales and earnings, reflecting softer performance and operational challenges. Management outlined a targeted restructuring of the North America water treatment business and plans for price increases to address higher input costs. A. O. Smith, a manufacturer of water heaters and water...

If you are wondering whether Progressive's current share price reflects its true worth, you are not alone. This article will help you frame that question clearly. The stock recently closed at US$199.31, with returns of a 0.8% decline over 7 days, 3.1% over 30 days, a 6.0% decline year to date, and a 25.0% decline over the last year, set against a 68.4% gain over 3 years and 111.9% over 5 years. Those moves have come alongside ongoing attention on Progressive's position in the US insurance...

If you are wondering whether Aflac's current share price reflects its true worth, the recent performance gives you a useful starting point for a closer look at value. The stock last closed at US$112.88, with a 7 day return of a 1.5% decline, a 30 day return of 3.0%, a year to date return of 2.4% and a 1 year return of 9.3%, set against very large gains over 3 and 5 years. Recent news coverage has focused on Aflac as a long established insurer with a strong brand and ongoing investor interest...

DigitalBridge Group (DBRG) continues to draw attention as investors weigh its role in digital infrastructure against recent share performance. The stock last closed at US$15.55 and has a market value of about US$2.9b. See our latest analysis for DigitalBridge Group. While the recent 1-day and 7-day share price returns are slightly negative, DigitalBridge Group’s 1-year total shareholder return of 69.55% contrasts with a 5-year total shareholder return decline of 43.82%. This suggests momentum...

Q3 2026 earnings snapshot and how the story stacks up Clorox (CLX) has just posted Q3 2026 results with revenue of US$1,670 million and basic EPS of US$1.54, setting the tone for how investors read its latest trading update. Over the past few quarters the company has seen revenue move in a tight band around US$1,670 million while basic EPS has ranged from US$0.65 in Q1 2026 to US$2.70 in Q4 2025, giving you a clear view of how earnings swing through the year. With trailing twelve month...

Luckin Coffee (OTCPK:LKNC.Y) reported strong Q1 2026 results with a 35% year over year revenue jump. The company added more than 2,500 new stores globally during the quarter. Management approved a US$300 million share repurchase program aimed at returning capital to shareholders. At a share price of $35.24, Luckin Coffee comes into this update after an 11.9% gain over the past week and a 7.5% return over the past month, while sitting roughly flat year to date. The stock has delivered a very...

Brunswick (BC) opened 2026 with Q1 revenue of US$1.4 billion and basic EPS of US$0.32, supported by net income excluding extra items of US$21 million. The company has seen quarterly revenue move from US$1.22 billion in Q1 2025 to US$1.38 billion in Q4 2025 and US$1.38 billion again in Q1 2026. Over the same period, basic EPS has ranged from US$0.31 to US$0.90 and included a loss of US$3.57 in Q3 2025. Taken together, these figures present a mixed picture for margins as investors assess how...

If you are wondering whether Solstice Advanced Materials at around US$80.59 is still offering value or if you might be late to the story, this article breaks down what the current price could mean for you. The stock has been volatile recently, with a 0.9% decline over the last 7 days, a 5.5% gain over the last month, and a 63.5% return year to date. Recent coverage has focused on Solstice Advanced Materials as investors look more closely at advanced materials names, with attention on how...

Apple (AAPL) has reported Q2 2026 revenue of US$111.2b and basic EPS of US$2.02, with net income of US$29.6b setting the tone for this earnings update. Over recent quarters, revenue has moved from US$95.4b in Q2 2025 to US$102.5b in Q4 2025 and then to US$111.2b in Q2 2026, while quarterly basic EPS over the same periods was US$1.65, US$1.85 and US$2.02 respectively. With trailing 12 month earnings up 26% and net profit margins at 27.2%, investors now have a clearer view of how Apple is...

Apellis Pharmaceuticals (NasdaqGS:APLS) is scheduled to present at the 2026 Cell & Gene Meeting on the Mediterranean. The conference appearance will focus on the company’s cell and gene therapy programs. The event is expected to draw interest from biotech specialists and investors who track emerging therapeutic platforms. Apellis Pharmaceuticals (NasdaqGS:APLS) is known for work in complement biology, and its upcoming presence at the 2026 Cell & Gene Meeting on the Mediterranean puts a...

Kaiser Aluminum Corporation recently reported past first-quarter 2026 results, with sales rising to US$1,106.8 million and net income reaching US$62.5 million, driving higher basic and diluted earnings per share from continuing operations. This surge in profitability, coupled with analyst earnings estimate revisions and broader attention from market commentators, highlights a shift in how the company’s earnings power is being assessed. Now, we'll examine how this stronger-than-expected...

Wondering whether Sonic Automotive's current share price lines up with its underlying value, or if the recent attention has run ahead of the fundamentals? The stock last closed at US$76.43, with returns of 6.4% over 7 days, 17.1% over 30 days, 24.0% year to date, 24.5% over 1 year, 101.2% over 3 years and 64.1% over 5 years. These figures may catch the eye of investors reviewing performance over different time frames. Recent coverage of US auto retailers has focused on how dealers are...

ABM Industries recently announced that Vanderbilt University selected it to deliver its end-to-end ABM Performance Solutions model for the institution’s New York City campus, overseeing operations from renovation and startup through ongoing maintenance across cleaning, engineering, grounds, subcontract management, and event support. At the same time, filings showed that Vanguard entities now hold passive stakes of about 7% and 5% in ABM, highlighting continued institutional interest even as...

If you are wondering whether Definium Therapeutics at around US$21.70 still offers value after a strong run, this review of its pricing is designed to help you frame that question clearly. The stock has delivered a 59.1% return year to date and a 213.1% return over the last year, with shorter term moves including a 5.3% return over 30 days and a 3.5% decline over the past week. These swings sit against a longer track record where the 3 year return is very large at roughly 7x, while the 5...

Organon (NYSE:OGN) has agreed to be acquired by Sun Pharmaceutical Industries in an all cash deal valued at about $11.75b. The transaction is expected to close in early 2027, after which Organon is set to be delisted from the NYSE. Separately, Organon and Henlius have received European marketing approval for POHERDY, the first biosimilar to PERJETA. For investors watching NYSE:OGN, these developments arrive after a sharp recent move in the share price. The stock closed at $13.29, with...

Warrior Met Coal (HCC) opened Q1 2026 with total revenue of US$458.6 million and basic EPS of US$1.37, alongside net income of US$72.3 million, as the market weighs these fresh numbers against a current share price of US$86.20. Over the last six reported quarters, the company has seen quarterly revenue move from US$297.5 million in Q4 2024 to US$302.6 million in Q1 2025 and then to US$458.6 million in Q1 2026. Basic EPS shifted from US$0.02 in Q4 2024 to a loss of US$0.16 in Q1 2025 and then...

With FMC shares back at US$14.82, many investors are asking the same question: is the current price a rare value opportunity or a sign to stay cautious? Over the last week the stock slipped 0.4%, extended to a 13.6% decline over the past month, while still showing a 3.3% gain year to date against a much steeper 59.1% loss over the past year and an 85.6% and 85.3% decline over the last 5 and 3 years respectively. Recent market attention has focused on the scale of FMC's multi year share price...